|
MIF expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.809600E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.582880E-03 |
| Normal-vs-Stage2 |
3.860200E-02 |
| Normal-vs-Stage3 |
1.036600E-03 |
| Normal-vs-Stage4 |
2.297700E-02 |
| Stage1-vs-Stage2 |
7.905600E-01 |
| Stage1-vs-Stage3 |
4.313400E-01 |
| Stage1-vs-Stage4 |
8.817200E-01 |
| Stage2-vs-Stage3 |
7.935800E-01 |
| Stage2-vs-Stage4 |
9.268200E-01 |
| Stage3-vs-Stage4 |
6.888800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.403700E-04 |
| Normal-vs-AfricanAmerican |
3.249600E-01 |
| Normal-vs-Asian |
8.699500E-02 |
| Caucasian-vs-AfricanAmerican |
1.480150E-01 |
| Caucasian-vs-Asian |
5.390600E-01 |
| AfricanAmerican-vs-Asian |
5.566600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.94800000000406E-05 |
| Normal-vs-Female |
2.284600E-03 |
| Male-vs-Female |
9.340200E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.717800E-03 |
| Normal-vs-Age(41-60Yrs) |
6.620000E-03 |
| Normal-vs-Age(61-80Yrs) |
4.138600E-03 |
| Normal-vs-Age(81-100Yrs) |
8.317000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.991200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.673600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.259600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.419200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.954000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.116000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.749600E-01 |
| Classical-VS-Follicular |
1.600200E-02 |
| Classical-VS-Other |
5.848200E-01 |
| Classical-VS-Normal |
2.115500E-02 |
| Tall-VS-Follicular |
2.724200E-02 |
| Tall-VS-Other |
3.086800E-01 |
| Tall-VS-Normal |
3.811600E-01 |
| Follicular-VS-Other |
8.029800E-01 |
| Follicular-VS-Normal |
4.570800E-04 |
| Other-VS-Normal |
1.070650E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.757250E-04 |
| Normal-vs-N1 |
1.80150999999906E-05 |
| N0-vs-N1 |
1.757560E-02 |
|
|
